Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012808
Filing Date
2025-05-13
Accepted
2025-05-13 17:05:39
Documents
1
Period of Report
2025-05-12

Document Format Files

Seq Description Document Type Size
1 form4-05132025_050535.html 4  
1 form4-05132025_050535.xml 4 3389
  Complete submission text file 0001415889-25-012808.txt   4920
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Issuer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GENELUX CORPORATION 2625 TOWNSGATE RD., STE. 230 WESTLAKE VILLAGE CA 91361
Business Address
Zindrick Thomas (Reporting) CIK: 0001937573 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41599 | Film No.: 25941232